Wild type, dEX3 and 2B survivin isoforms localize to the tumor cell plasma membrane, are secreted in exosomes, and interact with extracellular tubulin
The Inhibitor of Apoptosis Protein survivin (svn) is upregulated in nearly all types of cancer and represents a promising therapeutic target. Localization to specific subcellular compartments and interactions with various binding partners allow survivin to play diverse roles in apoptosis resistance...
Main Authors: | Sheila Figel, Meaghan Birkemeier, Sanam Sahjram Dharma, Tara Barone, Emma Steinmetz, Michael Ciesielski, Robert Fenstermaker |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-12-01
|
Series: | Biochemistry and Biophysics Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405580821002685 |
Similar Items
-
Survivin Small Molecules Inhibitors: Recent Advances and Challenges
by: Najah Albadari, et al.
Published: (2023-02-01) -
The role of survivin in the pathogenesis of genital endometriosis, current application possibilities (literature review)
by: Elena V. Misharina, et al.
Published: (2020-12-01) -
Inhibition of Survivin Homodimerization Decreases Neuroblastoma Cell Growth
by: Carmen Dorneburg, et al.
Published: (2023-12-01) -
Determination of Serum Survivin for Prognostic Role in Esophageal Cancer
by: Ali Mahmoodi, et al.
Published: (2020-02-01) -
Targeting survivin in leukemia
by: Bing Z. Carter, et al.
Published: (2011-12-01)